Posts Tagged: Stem cell

News

State gives $51 million to college students for stem cell research

Berkeley City College, which received a portion of $51 million in state stem cell research grants. (Photo: berkeleyside.org)

The California stem cell agency has awarded $51 million to help train students in the art of research at the Golden State’s community colleges and universities. All 15 applicants for awards that ran as high as $3.6 million each were approved, including Berkeley City College, which was initially rejected by anonymous reviewers who met privately prior to the ratification of their decisions by the agency’s directors.

News

Stem cell agency says it’s going all out on ‘bubble baby’ cure

A scientist at work in a biomedical laboratory. (Photo: Tom Robertson, via Shutterstock)

The California stem cell agency says it is doing “everything” it can to move forward on a gene therapy that has saved the lives of more than 50 persons but which has been pushed aside by the company that has exclusive rights to it. The issue has raised questions about the ethics of withholding care from babies and children suffering from a fatal disease.

News

State stem cell agency follows the money — $5.5 billion

A pipette and receptacles used in stem cell research. (Photo: CI Photos)

The talk at the California stem cell agency this week was of ”boiling the ocean,” the meaning of “unlikely” and “DEI.” All of which involves how $5.5 billion in taxpayer dollars will be used over the next decade or so.

News

UC Davis: First clinical trial of stem cells to treat spina bifida

A stem cell researcher at UC Davis. (Photo: AJ Cheline, UC Davis, via The Stem Cellar)

Backed by $17 million in cash from California’s stem cell agency, researchers at UC Davis this month are launching “the world’s first clinical trial using stem cells to treat spina bifida before the child is born.”

Opinion

Prop. 14 will continue CA’s life-saving stem cell research

A liquid nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich, via Shutterstock)

OPINION: The Golden State boasts the 5th largest economy, the biggest and best public university systems and, thanks to support from California voters, it’s the global epicenter for advancing stem cell research and treatments for chronic diseases and conditions that will afflict nearly all California families.

News

CIRM board member, former chair tangle over Prop. 14

Robert Klein, left, and CIRM board member Jeff Sheey, right. At center is Board Vice Chair Art Torres. (Photo: California Stem Cell Report)

The two men once worked together over the last 16 years to spend $3 billion in state funds on stem cell research in California. This week, however, they were very publicly on opposite sides of a ballot initiative to spend $5.5 billion more. The initiative is Proposition 14, which would require the state to borrow the additional billions.

News

Proposition 14: There’s much, much more than meets the eye

Personnel at UCSF's facility in Fresno, which may benefit if Proposition 14 is approved. (Photo: UCSF)

Proposition 14, the fall ballot measure to save California’s stem cell agency from financial extinction, contains much, much more than the $5.5 billion that it is seeking from the state’s voters. Added to the agency’s charter would be research involving mental health, “therapy delivery,” personalized medicine and “aging as a pathology.“ That is not to mention a greater emphasis on supporting “vital research opportunities” that are not stem cell-related.

News

Stem cell agency OKs firm’s clinical trial lauded by Giuliani

Rudy Giuliani, left, and Robert Hariri. (Photo: Hariri Twitter page.)

California’s stem cell agency last week awarded $750,000 to a New Jersey firm to help finance a clinical trial for the firm’s proposed Covid-19 treatment — a therapy that has been hailed by President Trump’s personal attorney as having “real potential.” The firm is Celularity, Inc. Its president and co-founder is Robert Hariri, who describes himself as a longtime friend of Rudy Giuliani.

Recent News

$5.5 billion stem cell rescue plan makes November ballot

A cancer stem cell researcher in the laboratory. (Photo: science photo, via Shutterstock)

A $5.5 billion stem cell bond measure qualified this afternoon for the November ballot, but the campaign to win voter approval is facing an array of hurdles that its supporters never envisioned last summer when they were formulating the initiative.

News

Stem cell initiative poised to qualify for November

Signature gathering during the 2018 election cycle. (Photo: Michael Gordon, via Shutterstock)

The $5.5 billion California stem cell initiative is virtually certain to qualify for the fall ballot as the arithmetic of the signature count begins to fall into place. The measure needs only slightly more than the 67 percent of the signatures that remain to be verified as coming from registered voters. The qualification percentage of raw signatures so far is 78 percent.

Support for Capitol Weekly is Provided by: